AI assistant
BOSTON SCIENTIFIC CORP — Director's Dealing 2023
Oct 10, 2023
29821_dirs_2023-10-10_e9bbc0fe-073d-4c46-8c37-48adf8704009.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2023-10-09
Reporting Person: Mahoney Michael F (Director, Chairman, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-10-09 | Common Stock | M | 57680.0000 | $13.0800 | Acquired | 1556602.0000 | Direct |
| 2023-10-09 | Common Stock | M | 55675.0000 | $16.3100 | Acquired | 1612277.0000 | Direct |
| 2023-10-09 | Common Stock | S | 113355.0000 | $52.0884 | Disposed | 1498922.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-10-09 | Stock Option (Right to Buy) | $16.3100 | M | 55675.0000 | Disposed | 2025-02-23 | Common Stock (55675.0000) | Direct |
| 2023-10-09 | Stock Option (Right to Buy) | $13.0800 | M | 57680.0000 | Disposed | 2024-02-24 | Common Stock (57680.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 176245.0000 | Indirect |
Footnotes
F1: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 24, 2023, intended to comply with the prior version of Rule 10b5-1(c).
F2: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $51.83 to $52.41, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant.
F4: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.